2 most recent filings and news items mentioning BKYI. Updated every 60 seconds.
RegulatoryJul 7, 2026Positive
BIO-key International announced its shares will resume trading on Nasdaq starting July 8, following a panel's decision that the company has regained compliance with listing requirements. This regulatory clearance mitigates the risk of direct delisting and restores access to capit
View filing at SEC.gov →
RegulatoryJun 10, 2026Negative
BIO-key International received a notice from Nasdaq stating the company failed to timely file its Form 10-Q for the quarter ended March 31, 2026, violating Listing Rule 5250(c)(1). The Nasdaq Hearing Panel will determine whether the company maintains its listing on Nasdaq Capital
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.